Auszug
Die weibliche Gonadentätigkeit ist durch das recht regelmäßige Auftreten von Ovulationen und Menstruationsblutungen gekennzeichnet. Das Regelkreissystem und die beteiligten Hormone an diesen Ereignissen sind in ⊡ Abb. 63.1 bzw. ⊡ Abb. 63.2 dargestellt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abramov Y, Fatum M, Abrahamov D, Schenker JG (2001) Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 75:1228–1230
Arbeitsgemeinschaft Diabetes und Schwangerschaft der Deutschen Diabetesgesellschaft (DDG), Arbeitsgemeinschaft für maternofetale Medizin (AGMFM) der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und Deutsche Gesellschaft für Perinatale Medizin (2001) Empfehlungen zu Diagnostik und Therapie des Gestationsdiabetes 2001
Barbieri RL, Hornstein MD (1999) Assisted reproductionin vitro ferlilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropinreleasing hormone analogues. Endocr Rev 20: 249–252
Conway GS (2000) Premature ovarian failure. Br Med Bulletin 56: 643–649
Cosman F, Lindsay R (1999) Selective estrogen receptor modulators: Clinical spectrum. Endocr Rev 20:418–434
Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 18:774–800
Eismann JA (1999) Genetics of osteoporosis. Endocr Rev 20:788–804
Ellis MH, Beyth Y (1999) Abnormal vaginal bleeding in adolescence as the presenting symptom of a bleeding diathesis. J Pediatr Adolesc Gynecol 12:127–131
Favus MJ (1999) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams & Wilkins, Philadelphia
Filicori M, Flamigni C (1996) The ovary: Regulation, dysfunction and treatment. International Congress Series 1106. Elsevier, Amsterdam
Filicori M, Santoro N, Merriam G, Crowley WF Jr (1986) Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocinol Metab62:1139
Hammond MG (1984) Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction. Fertil Steril 42:499
Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HPG (1994) Evaluation der klimakterischen Beschwerden. [Menopause Rating Scale (MRS)]. Zentralbl Gynäkol 116:16
Henderson VW (2000) Hormone therapy and the brain — A clinical perspective on the role of estrogen. The Parthenon Publishing Group, New York London
Hinney B, Henze C, Wuttke W (1995) Regulation of luteal function by luteinizing hormone and prolactin at different times of the luteal phase. Eur J Endocrinol 133:701
Hinney B, Henze C, Kuhn W, Wuttke W (1996) The corpus luteum insufficiency: A multifactorial disease. J Clin Endocrinol Metab 81:565–570
Kemmeren JM, Algra A, Grobbee DE (2001) Third generation oral contraceptives and risk of venous thrombosis: metaanalysis. BMJ 323:131–134
Leyendecker G, Wildt L (1983) Induction of ovulation with chronic intermittent (pulsatile) administration on Gn-RH in women with hypothalamic amenorrhea. J Reprod Fertil 69:397
Ludwig M, Bauer O, Diedrich K (1997) Überblick über das ovarielle Überstimulationssyndrom: ein reproduktionsmedizinischiatrogenes Krankheitsbild mit internistischer Konsequenz. Wien Med Wochenschr 147:516–524
Ludwig M, Felberbaum RE, Devroey P, Albano C, Riethmuller-Winzen H, Schuler A, Engel W, Diedrich K (2000) Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 264:29–32
Lunenfeld B, Insler V, Glezerman M (1992) Diagnosis and treatment of functional intertility. Blackwell, London
Marchbanks PA, McDonald JA, Wilson HG et al. (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346: 2078–2079
Nicolaides KH (2005) First-trimester screening for chromosomal abnormalities. Semin Perinatol. 29:190–4
Penzias AS (2002) Luteal phase support. Fertil Steril 77:318–323
Pinkerton JV, Santen R (1999) Alternatives to the use of estrogen in postmenopausal women. Endocr Rev 20:308–320
Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC (1999) The insulinrelated ovarian regulatory system in health and disease. Endocr Rev 20:535–582
Prior JC (1998) Perimenopause: The complex endocinology of the menopausal transition. Endocr Rev 19:397–428
Schenker JG (1999) Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 85:13–20
Speroff L, Glass RH, Kase NG (1999) Clinical Gynecologic endo-crinology and infertility, 6th edn. Lippincott Williams & Wilkins, Baltimore
Tartaryn IV, Meldrum DR, Lu KH, Frumar AM, Judd HL (1979) LH, FSH and skin temperature during the menopausal hot flash. J Clin Endocrinol Metab 49:152–154
Wu O, Robertson L, Langhorne P et al. (2005) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thromb Haemost 94:17–25
Wuttke W, Pitzel L, Seidlová-Wuttke D, Hinney B (2001) LH pulses and the corpus luteum: The luteal phase deficiency (LPD). Vitamins and Hormones 63:131–157
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Wuttke, W., Hinney, B. (2007). Störungen der weiblichen Gonaden. In: Schölmerich, J. (eds) Medizinische Therapie 2007 | 2008. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48554-4_63
Download citation
DOI: https://doi.org/10.1007/978-3-540-48554-4_63
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-48553-7
Online ISBN: 978-3-540-48554-4
eBook Packages: Medicine (German Language)